Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

An investigative report revealed that Canopy Growth was involved in a 1500 pound marijuana bust. Marijuana remains a risky market, politically.

Canopy Growth Implicated in Massive Pot Bust and Cover Up

Canopy Growth Corp (NYSE: CGC) recently announced a deal to acquire U.S. cannabis company Acreage Holdings Inc (OTC: ACRGF) that is contingent on U.S.

Analyst: Acreage Deal Part Of Canopy Growth's 'One Step Ahead' Mentality

CGC stock is in sell-off mode, but as the stock closes in on $40, this sell-off of Canopy stock could be approaching its final inning.
The post Why Investors Should Buy Canopy Growth Stock appeared first on InvestorPlace.

Why Investors Should Buy Canopy Growth Stock

Aurora Cannabis

Aphria

Cronos Group

HEXO Corp

Tilray Brands

Marijuana investors' favorite stocks are anywhere from 25% to 84% below their all-time highs.

Every Popular Pot Stock Is Now in Bear Market Territory

Canopy Growth stock is the pot industry's "best investable opportunity," Stifel analysts said, even as they remained cautious on other marijuana stocks.  
The post Why Canopy Growth Is The Most 'Investable' Of Canada's Marijuana Stocks appeared first on Investor's Business Daily.

Why Canopy Growth Is The Most 'Investable' Of Canada's Marijuana Stocks

A wave of Wall Street analysts are initiating coverage of the cannabis space for the first time, and Stifel is the latest firm to weigh in on Canopy Growth Corp (NYSE: CGC).

Stifel: Canopy Growth Is The 'Best Investable Opportunity' In Cannabis

Canopy Growth stock has taken a hit lately.   But this looks like a good opportunity to buy CGC stock on weakness.

Should Investors Buy Canopy Stock as Cannabis Legalization Gains Momentum?

Canadian-based cannabis and hemp company Canopy Growth Corp (NYSE: CGC) is looking to open hemp facilities across seven U.S.

Canopy Growth Details Some US Expansion Plans

Plunging share prices make it easy to fall into this trap.

The Biggest Mistake Marijuana Stock Investors Are Making Right Now

Of course, the medical opportunity is massive, but Tilray competitor, Canopy Growth (NYSE:CGC), has been aggressively pursuing a multi-pronged approach that inherently diversifies the future revenue streams. CGC’s vision for THC as an ingredient in an array of consumer products separates them from an increasingly crowded industry.

Continued Smart M&A Moves Will Help Canopy Stock Break Out

Canopy Growth and Acreage Holdings announced an important merger between the biggest pot company in the US and the biggest pot company in the world.

The Canopy-Acreage Merger Opportunity

Major North American growers could lose business to lower-cost Colombian producers.

Why Colombia Poses a Threat to Cannabis Stocks

Although mixed news from the FDA hearing will probably not hurt Canopy Growth, it could lead to questions about the valuation of CGC stock.
The post FDA Hearing Won’t Hurt Canopy’s Growth, But It Could Hit CGC Stock appeared first on InvestorPlace.

FDA Hearing Won’t Hurt Canopy’s Growth, But It Could Hit CGC Stock

GW Pharmaceuticals

Analysts estimate that nearly 65 million Americans have tried CBD and 63% have found it effective. What's more, CBD is a growing industry with sales expected to rise 55% to $648 million in 2019.

4 CBD Stocks to Win Big in June

Village Farms International

Hemp provides the perfect opportunity to get infrastructure in place, if and when the U.S. government ever changes its tune on cannabis.

4 Canadian Pot Stocks Making the Legal Leap Into the U.S. Hemp Market

The most popular marijuana stock has been outperformed by a variety of cannabis growers.

3 Pot Stocks That Have Left Aurora Cannabis Eating Their Dust Since the Beginning of 2018

Acreage is active in every state that lets it in, but marijuana remains a schedule drug under U.S. law. Canopy shareholders are betting that changes soon.

Canopy Growth Stock Needs Outside Help to Keep Growing

In a November discussion with CNBC’s Jim Cramer, Canopy Growth Co-CEO Bruce Linton discussed the sleep-aid market, one of four areas the company is looking to disrupt: the others are opioids, sports recovery drinks, and pot for pets. 
The post This Latest Acquisition Gives a Glimpse into the Future for Canopy Stock appeared first on InvestorPlace.

This Latest Acquisition Gives a Glimpse into the Future for Canopy Stock

Two investment banks are bullish for some, but not all, of the same big cannabis stocks.

3 Marijuana Stocks That Wall Street Thinks You Should Buy

CannTrust Holdings

These are the pot stocks truly expected to "deliver the green."

Ranking Canada's Top 10 Marijuana Growers

CBD represents a huge opportunity -- and these three stocks are poised to capitalize on it.

Top CBD Stocks to Buy in June

Here's what the maturation process for marijuana stocks will probably entail.

What's Next for Pot Stocks After Capacity Expansion?

Cara Therapeutics

Insys Therapeutics

Amplify Alternative Harvest ETF

Scotts Miracle-Gro

Should you put your hard-earned money into these stocks? We detail the investment opportunities, the risks, and regulations in the cannabis space.

Investing in Marijuana Stocks: Everything You Need to Know

Innovative Industrial Properties

Marijuana stocks were down Friday as the Food and Drug Administration began its first public hearing on CBD with a cautionary note.

Marijuana Stocks Fall As FDA Chief Sees 'Real Risks' In CBD Products

Canopy Growth Corp (NYSE: CGC)'s $3.4-billion proposed acquisition of U.S. multistate cannabis operator Acreage Holdings Inc (OTC: ACRGF) will position the company for the "next wave" of cannabis, Canopy co-founder and CEO Bruce Linton told CNBC's Jim Cramer.

News for Canopy Growth Stock (CGC)